SCHEMBL24095461

SCHEMBL24095461

Cc1cccc(-n2nc(C)cc2Oc2ccnc(Cl)c2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.47
▸ NPBWR1 P48145 3/20 0.40
▸ MCHR1 Q99705 2/20 0.40
▸ POLB P06746 1/20 0.40
▸ SCN9A Q15858 1/20 0.39
▸ TGFBR1 P36897 2/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ PAX8 Q06710 1/20 0.37
▸ P2RY1 P47900 1/20 0.37
▸ MAPT P10636 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ LMNA P02545 3/20 0.35
▸ GAA P10253 2/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ ALPG P10696 1/20 0.35
▸ NPSR1 Q6W5P4 1/20 0.35
▸ HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24095387 0.81 TGFBR1 (0.38) ALDH1A1POLBSCN9ATGFBR1MAPT
SCHEMBL24095451 0.77 KDM5A (0.39) ALDH1A1POLBTGFBR1L3MBTL1MAPT
SCHEMBL7214429 0.76 ALDH1A1 (0.50) ALDH1A1NPBWR1MCHR1TGFBR1L3MBTL1
SCHEMBL24095449 0.74 TGFBR1 (0.49) POLBTGFBR1
SCHEMBL24095413 0.73 TGFBR1 (0.47) TGFBR1
SCHEMBL24095415 0.69 TGFBR1 (0.43) TGFBR1
SCHEMBL27539022 0.68 SCN9A (0.51) ALDH1A1POLBSCN9AL3MBTL1P2RY1
SCHEMBL24095394 0.68 IRAK4 (0.38) TGFBR1
SCHEMBL8338087 0.67 ALDH1A1 (0.69) ALDH1A1POLBL3MBTL1NPC1RAB9A
SCHEMBL190684 0.67 HSP90AA1 (0.41) L3MBTL1HTTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220098171-A1 5-(4-PYRIDYLOXY)PYRAZOLE COMPOUNDS SERVING AS TGF-ßR1 KINASE INHIBITOR JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD. (CN) 2022-03-31 — — US disclosed
EP-3922631-A1 5-(4-PYRIDYLOXY)PYRAZOLE COMPOUNDS SERVING AS TGF-BETA R1 KINASE INHIBITOR Jiangsu AoSaiKang Pharmaceutical Co., Ltd. (CN) 2021-12-15 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220098171-A1 5-(4-PYRIDYLOXY)PYRAZOLE COMPOUNDS SERVING AS TGF-ßR1 KINASE INHIBITOR TGFBR1, TGFBR2, TGFB1 ALDH1A1 1561/4885NPBWR1 1268/4885MCHR1 3169/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback